Journal of Hepatology
Volume 48 , Pages S38-S57 , 2008

The challenges in primary sclerosing cholangitis – Aetiopathogenesis, autoimmunity, management and malignancy

  • Image Result

    Typical examples of PSC cholangiograms. (A) Type I intrahepatic alterations, (B) Type II intraheptic alterations, (C) Type III intraheptic alterations.

    Typical examples of PSC cholangiograms. (A) Type I intrahepatic alterations, (B) Type II intraheptic alterations, (C) Type III intraheptic alterations.

  • Image Result

    Secondary biliary sclerosis can mimick cholangiographic features of PSC. (A) The cholangiogram of a patient with ischemic-like cholangiopathy and biliary cast formation after prolonged anamnestic poly

    Secondary biliary sclerosis can mimick cholangiographic features of PSC. (A) The cholangiogram of a patient with ischemic-like cholangiopathy and biliary cast formation after prolonged anamnestic polytrauma with sepsis and mechanical ventilation. (B) A biliary cast that had been removed from the hepatic duct in this patient.

  • Image Result
    ERC with the corresponding MRC of two patients with PSC. Patient A presents with multifocal strictures of the intrahepatic bile ducts and with a high-grade stenosis at the cystic duct junction. Patien

    ERC with the corresponding MRC of two patients with PSC. Patient A presents with multifocal strictures of the intrahepatic bile ducts and with a high-grade stenosis at the cystic duct junction. Patient B features a long-segment filiform stenosis of the common bile duct; the intrahepatic ducts seem to be profoundly narrowed in ERC while MRC accentuates the dilated bile ducts in intervening segments.

  • Image Result
    Cholangiogram of a PSC patient. The arrow indicates a polypoid mass in the hilar region. Forceps biopsy revealed CC.

    Cholangiogram of a PSC patient. The arrow indicates a polypoid mass in the hilar region. Forceps biopsy revealed CC.

  • Image Result
    Cholangiogram (A) and cholangioscopic appearance (B) of a benign stricture in a patient with PSC.

    Cholangiogram (A) and cholangioscopic appearance (B) of a benign stricture in a patient with PSC.

  • Image Result
    Kaplan–Meier analysis of cumulative survival after liver transplantation from 01/2003 to 08/2007 at Hannover Medical School comparing 55 patients with PSC (incl. five patients with CC) and 318 patient

    Kaplan–Meier analysis of cumulative survival after liver transplantation from 01/2003 to 08/2007 at Hannover Medical School comparing 55 patients with PSC (incl. five patients with CC) and 318 patients with other chronic liver diseases (hepatitis B and C, alcoholic liver disease, hepatocellular carcinoma and others). The log-rank-test shows a significant better survival of patients with PSC (p<0.01).

 The Authors T.J. Weismüller, J. Wedemeyer, C.P. Strassburg and S. Kubicka state that they have nothing to declare regarding conflict of interest and funding with respect to this manuscript. M.P. Manns is an investigator/consultant/speaker at Novartis, Roche, Schering-Plough, Gilead Sciences Inc., Tibotec, Vertex, GlaxoSmithKline, Boehringer Ingelheim, Bristol-Myers Squibb, Idenix and Merck. M.P. Manns received meeting support and lecture fees from the Falk Foundation, Freiburg, Germany. M.P. Manns received funding from Deutsche Forschungsgemeinschaft (KF0119, SFB 621, SFB738), DFG Cluster of Excellence “Rebirth” and Transplantation centre.

PII: S0168-8278(08)00059-7

doi: 10.1016/j.jhep.2008.01.020

Journal of Hepatology
Volume 48 , Pages S38-S57 , 2008